Is Memantine legal in Poland?
Also known as: namenda
- Legal status
- Not named in the Polish national list. Memantine appears in none of the three annexes, so it is neither a narcotic nor a psychotropic nor a new psychoactive substance under the 2005 Act. It is a registered prescription medicine under Polish pharmaceutical law.
- Consequences if caught
- Capital exposure: none. Poland has no death penalty, and no drug offence attaches to this row at all on the list as read. No article 62 or article 62b offence arises, because each requires a substance specified in the regulation issued under article 44f. Unauthorised supply is a pharmaceutical law breach rather than a drug law one, and that regime was not read in this pass. This absence is stated as at the consolidated text of 17 June 2024, Dz.U. 2024 poz. 1139, as that text stands after the amending regulations of 30 April 2025, Dz.U. 2025 poz. 598, and of 7 July 2026, Dz.U. 2026 poz. 934, read at api.sejm.gov.pl on 21 September 2026. The power to move the list belongs to the Minister of Health, exercised by rozporządzenie under article 44f of the 2005 Act, and that does not rule out a later rozporządzenie made after the date of this reading.
- If prescribed or medical
- Prescribed for moderate to severe Alzheimer's dementia.
- Documentation
- Carry the original prescription. The published Poland entry names Memabix and Ebixa as registered products, and that is carried forward from the published Poland entry and was not re-derived in this pass.
- Rozporządzenie Ministra Zdrowia z dnia 17 sierpnia 2018 r. w sprawie wykazu substancji psychotropowych, środków odurzających oraz nowych substancji psychoaktywnych, tekst jednolity Dz.U. 2024 poz. 1139
- api.sejm.gov.pl
- Rozporządzenie Ministra Zdrowia z dnia 30 kwietnia 2025 r. zmieniające to rozporządzenie, Dz.U. 2025 poz. 598, w mocy od 22 maja 2025 r.
- api.sejm.gov.pl
- Rozporządzenie Ministra Zdrowia z dnia 7 lipca 2026 r. zmieniające to rozporządzenie, Dz.U. 2026 poz. 934, w mocy od 28 lipca 2026 r.
- api.sejm.gov.pl
- Ustawa z dnia 29 lipca 2005 r. o przeciwdziałaniu narkomanii, tekst jednolity Dz.U. 2023 poz. 1939, art. 4 pkt 25 i 26, art. 31, art. 32, art. 33, art. 44f, art. 62, art. 62a, art. 62b
- api.sejm.gov.pl
- the named registered products are carried forward from the published Poland entry and were not re-derived here
- gov.pl
- the regulation, both amending regulations and the Act were read at api.sejm.gov.pl on 21 September 2026
Want to know if Poland changes its law on Memantine?
Drug-law changes, court decisions and research, once a month.
Free. We email you once to confirm. Unsubscribe with one click.
Court records
We have not yet assessed whether court records are publicly available for this jurisdiction.
Memantine in related jurisdictions
Other substances confirmed in Poland
Same substance, other countries
Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Poland’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →